Long-Term Debt: The sum of all long term debt fields.
Oramed Pharmaceuticals Inc. (ORMP) Long-Term Debt data is not available.
| Income Statement Financials | |
$2.00M |
|
$63.24M |
|
$1.99M |
|
$0.01M |
|
$17.09M |
|
$-15.09M |
|
$90.41M |
|
$75.32M |
|
$75.32M |
|
$64.02M |
|
$64.02M |
|
$64.02M |
|
$64.02M |
|
$-15.09M |
|
$-14.97M |
|
41.40M |
|
42.42M |
|
$1.53 |
|
$1.40 |
|
| Balance Sheet Financials | |
$133.27M |
|
$0.59M |
|
$97.59M |
|
$230.86M |
|
$19.09M |
|
|
Long-Term Debt |
-- |
$12.03M |
|
$31.12M |
|
$199.74M |
|
$199.74M |
|
$199.74M |
|
39.27M |
|
| Cash Flow Statement Financials | |
$-9.14M |
|
$5.44M |
|
$-4.74M |
|
$54.42M |
|
$45.95M |
|
$-8.47M |
|
$5.99M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.98 |
|
-- |
|
-- |
|
-- |
|
-- |
|
0.65% |
|
-754.40% |
|
-754.40% |
|
-748.35% |
|
3766.20% |
|
3162.10% |
|
$-9.15M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
32.05% |
|
32.05% |
|
27.73% |
|
32.05% |
|
$5.09 |
|
$-0.22 |
|
$-0.22 |
|